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Introduction
With the improvement in surgical techniques, immunosup-
pression regimens,1 recipient preparation and organ preser-
vation, liver transplantation has become the accepted treat-
ment for end-stage liver disease. The 1-year patient survival
rate increased to about 85% in the 1990s.2 As a result, the
demand for transplantation has become greater than the
availability of donor livers. Faced with the growing discrep-
ancy between the demand for and supply of donor organs,
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many centres are trying to broaden their donor pool, for
example, by the use of non-heart-beating donors3 and the
initiation of living related liver transplantation.4 The use of
elderly donors is a possible means of expanding the donor
pool, but the impact of donor age on liver transplantation
outcome has yet to be clarified. Livers from donors older than
60 years are considered to be inadequate for transplantation
by many centres because older livers are more susceptible to
various hepatocyte insults.3,5,6 Recently, several reports have
pointed out that donors older than 60 years can be safely
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used.7–10 Kampmann et al indicated that, because of its great
functional reserve and regenerative capacity, the liver does not
usually suffer from functional deterioration with ageing.11
Therefore, utilization of liver grafts from elderly donors has
been advocated.5,6 From 1988 to 1993, the percentage of
elderly donors between the ages of 50 and 65 in the United
Network for Organ Sharing increased from 2.5% to 15.9%.
Based on these developments, some centres now routinely use
elderly donors to tackle the imbalance between the increasing
demand for liver transplantation and the inadequate supply of
donor organs.
The aim of this study was to review our experience with
transplantation of liver grafts from cadaveric donors over
the age of 60 years, to investigate the potential donor risk
factors for graft survival, and to compare early graft function
between patients receiving livers from donors over 60
years old and those receiving livers from donors aged 60 years
or less.
Patients and methods
We retrospectively evaluated 106 cadaveric liver transplan-
tations in 98 patients at Queen Mary Hospital, Hong Kong,
between October 1991 and June 2002. Seven patients (6.6%, 7
vs 106) received livers from donors older than 60 years. These
included one patient who received a second re-transplant and
one patient who received a fourth re-transplant. During the
study period, three grafts from donors older than 60 years
were not used because, at the harvesting operation, the grafts
were found to be cirrhotic (n = 2) or had severe (60–70%) steato-
sis. All grafts were procured and preserved using Universi-
ty of Wisconsin (UW) solution by the standard technique for
multiple organ harvesting, and all recipients had similar peri-
operative intensive care. All elderly donors were ABO identical
or compatible with the recipient. Two of 99 donors in the
younger group were ABO incompatible. All patients who
received livers from elderly donors received FK506-based dou-
ble immunosuppression therapy,1 whereas others received
cyclosporine-based triple or FK506-based double therapy.
Donors were examined intraoperatively. In the case of sus-
pected fatty infiltration, routine liver biopsy was performed.
The liver would not be used if it had apparent fibrosis, cirrho-
sis or steatosis (> 30%). Liver transplantations were performed
using the standardized method. In all cases, the cold ischaemia
time was kept as short as possible by preparing the recipient
for transplantation upon acceptance of the liver allograft by
the harvesting team.
The 106 cadaveric liver transplantations were categorized
into two groups. Group I included patients receiving grafts
from elderly donors (> 60 years), and Group II included pa-
tients receiving grafts from younger donors (≤ 60 years). We
recorded donor age, gender, body mass index (BMI), cause of
death, length of intensive care unit (ICU) stay, liver enzymes,
minimum systolic pressure and duration, and quantity of
inotrope used; these are the risk factors identified by Jimenez
Romero et al.12 For all recipients, we recorded pre-transplant
data (age, gender, liver enzymes), perioperative data including
platelet count, prothrombin time and cold ischaemia time,
postoperative liver enzymes, peak bilirubin, peak alanine ami-
notransferase and aspartate aminotransferase on days 1 to 7,
occurrence of primary non-function, and complications.
The pre-transplant status of recipients was compared be-
tween the two groups, as were the postoperative variables and
graft outcomes. Comparisons were made using the Mann-
Whitney U test and Fisher’s exact test. Data are expressed as
median (range). A difference was considered significant if p
was less than 0.05. A Cox univariate analysis was constructed
to identify the donor risk factors on long-term graft survival.
Afterwards, a multivariate forward stepwise Cox model was
constructed with donor variables. Actuarial graft and recipi-
ent survival analyses were performed using the Kaplan-Meier
method and compared using the log-rank test.
Results
The median follow-up was 22 months (range, 3–63.9 months)
in Group I and 28 months (range, 0.03–116 months) in Group
II. Table 1 summarizes donor and recipient characteristics in
Group I. In Group I, median donor age was 63 years (range, 61–
76 years). The cause of death was cerebrovascular accident in
five donors, carotid artery thrombosis in one donor, and trau-
matic subdural haemorrhage in one donor. Median donor
BMI was 22.68 (range, 19–26.22; BMI > 27 considered over-
weight12).
Three recipients had major complications. The patient
who received the second re-transplant had venous outflow
obstruction and biliary leakage 18 days after transplanta-
tion. We performed caval-caval anastomosis twice and
hepaticojejunostomy. Another recipient had minimal bile
leakage. Neither had hepatic artery thrombosis and both re-
covered after re-operation. One patient who is still alive but in
a vegetative state because of central pontine myelinolysis had
acute kinking of the hepatic artery without thrombosis. The
other three patients had no major complications, including
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the one who received the fourth re-transplant. Normalization
of aminotransferase levels and prothrombin times were noted
within 5 days after transplantation in four of the seven reci-
pients of elderly donor grafts. There were two total rejection
episodes among these seven patients. Four months after
transplantation, one patient died of hepatic artery thrombosis
before re-transplantation, despite normal postoperative liver
enzymes and prothrombin time. We retrospectively found
that this patient had severe atherosclerosis in the graft com-
mon hepatic artery.
Median recipient age was 44 years (range, 25–61 years) in
Group I and 44 years (range, 0.6–66 years) in Group II. The
preoperative status of recipients based on laboratory tests was
not significantly different between the two groups (Table 2).
The early intraoperative and early postoperative param-
eters and graft outcomes in the two groups are summarized
in Table 3 and Figures 1–4. Peak serum alanine aminotrans-
ferase and aspartate aminotransferase levels within 1 week
postoperatively were not significantly different between the
two groups. Peak serum total bilirubin levels, postoperative
aminotransferase levels, prothrombin times and platelet
counts on postoperative days 1 to 7 did not differ between
the two groups (p > 0.05). There was no significant differ-
ence in cold ischaemia time, primary non-function, re-
transplantation, occurrence of biliary complications, and he-
patic artery thrombosis. There were six re-transplants and one
primary non-function in Group II but no primary non-
function or re-transplantation in Group I. The number of
rejection episodes was two in Group I and 66 in Group II.
No donor risk factors had a significant effect on long-term
graft survival according to the Cox univariate analysis and
multivariate stepwise Cox model (Table 4). The 3-month cu-
mulative graft and patient survival rates were both 100% in
Group I and 84.3% and 87.8% in Group II, respectively. The 1-
Table 1. Characteristics of donors and recipients of elderly grafts
Donor age No. of donor CIT Recipient
Gender Diagnosis
Child-Pugh Patient Cause of graft
(yr) risk factors  (mins) age (yr) score outcome loss
61 3 443 44 M Hep B 13 Alive
61 3 702 39 M Hep B + drinker 9 Alive
61 3 402 47 M Hep B 6 Dead HA thrombosis
68 1 560 40 F Wilson’s disease 9 Alive
63 2 429 61 M Hep B + HCC 6 Alive
76 3 334 52 M Hep B 11 Alive
66 3 364 25 M Wilson’s disease 9 Alive
CIT = cold ischaemia time; M = male; Hep B = hepatitis B; HA = hepatic artery; F = female; HCC = hepatocellular carcinoma.
Table 2. Comparison of recipients’ pre-transplantation status
Group I (> 60 yr) Group II (≤ 60 yr)
n = 7 n = 99
Age (yr) 44 (25–61) 44 (0.6–66)
Total bilirubin (µmol/L) 74 (29–957) 70 (4–1,240)
ALP (U/L) 134 (74–290) 148 (42–1,560)
Creatinine (µmol/L) 100 (49–457) 91.5 (19–999)
BUN (mmol/L) 5 (4.1–24.1) 5.2 (1.2–34.3)
PT (mins) 17.1 (15–34) 17.4 (12–110)
Values expressed as median (range). ALP = alkaline phosphatase;
BUN = blood urea nitrogen; PT = prothrombin time.
year cumulative graft and recipient survival rates were 81.8%
and 77.8% in Group I and 82.9% and 85.1% in Group II, respec-
tively. There was no significant difference in survival between
the two groups.
Discussion
Traditionally, the use of liver allografts from donors older
than 60 years has been considered a major risk factor for
immediate and post-transplant poor graft function.13 The
results of our study suggest that it is unreasonable to reject
elderly donors just because of age. Early graft function and
graft and patient survival rates were not significantly different
between the two groups, and there were no instances of pri-
mary non-function and re-transplant in recipients of grafts
from elderly donors. In fact, this outcome is comparable with
that from Wall et al.14
Some reports show that many donor factors might have an
adverse impact on graft outcome.12,15 Jimenez Romero et al
identified risk factors to predict the prognosis for liver trans-
plantation that included age, gender, BMI, cold ischaemia
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Table 3. Comparison of perioperative parameters and recipient outcome
Group I (> 60 yr) Group II (≤ 60 yr)
Recipient age (yr) 44 (25–61) 44 (0.6–66)
CIT 429 (334–702) 444 (242–884)
Peak AST (U/L) 687 (184–1,390) 913 (146–10,000)
Peak ALT (U/L) 412 (216–871) 609.5 (63–6,860)
Peak bilirubin (µmol/L) 132  (82–542) 135.5 (28–999)
Primary non-function 0 1
Re-transplant 0 6
Biliary complication 3 11
Hepatic artery thrombosis 1 2
Mean follow-up (mo) 22 (3–63.9) 28 (0.03–116)
Graft survival (%)
   3-month 100 84.3
   1-year 81.8 82.9
Recipient survival (%)
   3-month 100 87.8
   1-year 77.8 85.1
Values expressed as median (range). CIT = cold ischaemia time; AST = aspartate aminotransferase; ALT = alanine aminotransferase.
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Figure 1. Postoperative prothrombin time. s  = Group 1; n  = Group 2.
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time, ICU stay, abnormal liver enzyme levels and high ino-
trope dosage.12 In this study, even though we had carefully se-
lected donors, we retrospectively found that there were 18 risk
factors among the seven elderly donors, and five of these
donors had three risk factors (Table 1). Therefore, it seemed
that this group was not comprised of optimal potential do-
nors. However, univariate and multivariate analyses could not
identify any impact of these risk factors on long-term graft
survival. The same results were observed in the studies of Bus-
quets et al16, Wall et al14 and Emre et al.5 Based on these results,
the value of traditional prognostic factors is questionable.
The success in our study can be attributed to many factors.
First, we did not allocate elderly donor grafts to critically ill
patients. A better result could be achieved by allocating such
grafts to recipients waiting at home.14 Second, the cold ischae-
mia time in our study was relatively short. One major risk
factor in aged liver is the susceptibility of the graft to ischae-
mia/reperfusion injury. It has been reported that livers from
elderly donors with cold ischaemia times of more than 12
hours have a deleterious impact on graft and recipient out-
comes.5,6 Therefore, it is our policy to avoid prolonged cold is-
chaemia times. The mean cold ischaemia time in our study was
less than 8 hours. Third, in our study, all donor assessments
were made by senior surgeons who had considerable experi-
ence with donor operations. According to one study, the
harvesting surgeon’s assessment of elderly donor livers had
a better correlation with graft survival than other more objec-
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Figure 2. Postoperative platelet count. s  = Group 1; n  = Group 2.
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Table 4. Possible donor prognostic risk factors for long-term graft survival
Univariate p Multivariate p
cRR (95% CI) aRR
Age > 60 yr 1.688 (0.228–12.491) 0.608 – 0.369
Gender (female) 0.821 (0.372–1.812) 0.625 – 0.784
BMI > 25 1.159 (0.192–3.874) 0.847 – 0.186
CIT > 720 mins 0.905 (0.148–8.218) 0.923 – 0.592
ICU stay > 3 days 1.013 (0.438–2.223) 0.975 – 0.637
AST > 36 U/L 1.156 (0.300–2.499) 0.789 – 0.721
ALT > 53 U/L 2.178 (0.519–3.827) 0.296 – 0.262
Total bilirubin > 34 µmol/L 0.709 (0.107–1.975) 0.500 – 0.722
High dose of inotrope 1.207 (0.505–2.887) 0.672 – 0.068
cRR = crude Relative Risk; CI = confidence interval; aRR =  adjusted Relative Risk; – = variables not in the equation; BMI = body mass index;
CIT = cold ischaemia time; ICU = intensive care unit; AST = aspartate aminotransferase; ALT = alanine aminotransferase.
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Figure 4. Postoperative serum alanine aminotransferase (ALT). s  =
Group 1; n  = Group 2.
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Figure 3. Postoperative serum total bilirubin level. s  = Group 1;
n  = Group 2.
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tive measures of the graft such as donor bilirubin, albumin,
creatinine and donor days in the hospital.17 All transplants
were performed by three experienced surgeons. Although it
cannot be demonstrated by data, we believe the judgement of
surgeons and the technique played an important role in the
function and survival of the graft. Fourth, all seven liver
transplantations from elderly donors were performed after
1997, when the more effective FK506-based immunosuppres-
sion regimen was used.1 This could have had an impact on
survival. Though there was no statistical significance, the total
number of rejection episodes in Group II (n = 66, 66.7%) was
higher than that in Group I (n = 2, 28.6%). Finally, we had a low
threshold for re-operation. Re-operation would be performed
immediately if a patient developed any signs of complications
that required emergency surgery. After re-operation, many
patients recovered very well.
Hepatic artery thrombosis remains the most common
technical complication that causes graft failure following
orthotopic liver transplantation. Therefore, hepatic artery
anastomosis should be performed using a meticulous tech-
nique and adequate magnification. There were three hepatic
artery thromboses (2.8%) in the entire study, and only one in
Group I (the patient’s hepatic artery had severe atheroscle-
rosis). This rate was a little higher than the 1.3% in the study
of Rela et al,18 who adopted the microvascular technique in
150 adult liver transplants. In our study, we did not use the
microvascular technique for hepatic artery anastomosis ex-
cept for a child. The microvascular technique should prob-
ably be used for elderly grafts to minimize the incidence of
hepatic artery thrombosis.
In conclusion, based on this study, we believe that livers
from elderly donors over 60 years of age can be safely used un-
der optimal protocols. Age alone is not an independent risk
factor for recipient survival. Exclusion of elderly donors has no
scientific foundation. The reliability of parameters that can
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predict graft function is still questionable. In Asia, the major
factor that limits the application of liver transplantation is the
shortage of donor grafts. Hence, relaxation of the selection
criteria for donors would be beneficial to potential recipients
who are suitable candidates for transplantation.
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